Geode Capital Management LLC Grows Position in HCA Healthcare, Inc. $HCA

Geode Capital Management LLC raised its stake in HCA Healthcare, Inc. (NYSE:HCA) by 0.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,663,705 shares of the company’s stock after buying an additional 13,565 shares during the period. Geode Capital Management LLC owned about 1.61% of HCA Healthcare worth $1,702,738,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently added to or reduced their stakes in HCA. Brighton Jones LLC purchased a new stake in HCA Healthcare in the 4th quarter valued at about $1,021,000. NewEdge Advisors LLC boosted its position in HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after buying an additional 409 shares during the period. Sivia Capital Partners LLC boosted its position in HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after buying an additional 33 shares during the period. Jump Financial LLC purchased a new stake in HCA Healthcare in the 2nd quarter valued at about $2,073,000. Finally, Sei Investments Co. boosted its stake in shares of HCA Healthcare by 56.3% during the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after purchasing an additional 49,214 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Down 2.1%

NYSE HCA opened at $384.01 on Friday. The firm has a market cap of $85.19 billion, a PE ratio of 13.21, a price-to-earnings-growth ratio of 1.24 and a beta of 1.18. The company has a 50 day moving average price of $454.43 and a 200 day moving average price of $481.46. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter last year, the firm earned $6.45 EPS. The company’s revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is presently 10.73%.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. Weiss Ratings lowered shares of HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, May 18th. Royal Bank Of Canada cut their price objective on shares of HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. UBS Group lifted their price objective on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a report on Monday, February 23rd. Robert W. Baird cut their price objective on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a research note on Tuesday, April 28th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $515.77.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.